BGB Group

What BGB Group does

BGB Group (operating commercially as BGBx) is a New York-headquartered, privately held commercial solutions partner to the pharmaceutical and life sciences industry, founded in 2005 and backed by TPG private equity since October 2021. The company delivers integrated services across two core pillars: a Strategic Advisory consulting practice (covering corporate and portfolio strategy, new product planning, medical and evidence strategy, commercial go-to-market, pricing and market access, patient affordability and services, and intelligence and analytics) and a Communications practice (advertising, medical communications, and payer communications). The firm also maintains a Technology Suite that supports these service lines, though specific product capabilities are not publicly detailed.

The company targets enterprise pharmaceutical and life sciences clients through a direct, relationship-driven sales motion, and earns revenue primarily through professional-services engagements priced on a quote basis. Its competitive positioning is built on deep therapeutic-area expertise — particularly in oncology, rare diseases, and metabolic/bone disease — and on the integration of consulting and communications under one roof across the full brand lifecycle, from clinical development planning through market access and patient engagement. BGB has scaled to between 501 and 1,000 employees and reported $145 million in 2024 revenue (4% YoY growth), with approximately half of incremental growth sourced from new clients.

The firm's growth strategy is heavily inorganic. It acquired Kx Advisors in September 2023 to expand into healthcare strategy consulting, and acquired Hayden Consulting Group in January 2026 to add payer, reimbursement, and patient-services expertise (integrating approximately 80-100 specialists into the Strategic Advisory practice under Chief of Commercial Strategy and Innovation Hilary Gentile). The company appointed Julie Yoon as Chief Client Officer in Q4 2025 to professionalize client engagement. The combined platform now operates from offices in New York (headquarters) and Boston, with leadership including founder and managing partner Gregory Passaretti, Chief Operating Officer Teresa Day, CFO Ken Boos, and Chief Digital Officer Fred Bennett.

Name

BGB Group

Legal name

BGB Group

Website

https://bgbgroup.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

501–1,000 employees

Short description

BGB Group (operating as BGBx) is a New York-based, TPG-backed commercial solutions partner providing integrated strategic consulting, communications, and technology services to pharmaceutical and life sciences companies across the full brand lifecycle.

Ownership category

akta.pro rank

Product category

Life Sciences Commercial Solutions

NAICS

Marketing Consulting Services (541613), Advertising Agencies (541810), Management Consulting Services (54161)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

B2B / Account-Based Marketing (ABM) Strategy Consulting (MPAAAFAM)

akta.pro secondary industries

Customer Experience (CX) & Digital Experience (BPAHAEAC), B2B / Industrial Market Research (MPAAALAA)

Keywords

• Pharmaceutical consulting services
• Medical communications
• Market access strategy
• Commercial strategy consulting
• Payer communications

Headquarters

HQ city

New York

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D

Revenue model

1. Consulting Services: Strategic consulting services including corporate & portfolio strategy, new product planning, medical & evidence strategy, commercial & go-to-market strategy, pricing & market access, and patient affordability & services
2. Communications Services: Advertising, medical communications, and payer communications services for life sciences companies

Go-to-market motion2 records

Distribution channels1 record

Marketing channels3 records

Core offering

BGB Group is a commercial solutions partner to the life sciences industry, providing integrated consulting and communications services to pharmaceutical companies. Its Consulting practice spans Corporate & Portfolio Strategy, New Product Planning, Medical & Evidence Strategy, Commercial & Go-to-Market Strategy, Pricing & Market Access, Patient Affordability & Services, and Intelligence & Analytics. Its Communications practice spans Advertising, Medical Communications (Med Comms), and Payer Communications. The firm also maintains a Technology Suite supporting these services and operates a Strategic Advisory practice strengthened by the acquisitions of Kx Advisors and Hayden Consulting Group.

Product overview

BGB Group (operating as BGBx) is a commercial solutions partner to the life sciences industry, offering an integrated portfolio of consulting and communications services. The company operates as a unified platform combining Strategic Advisory consulting services (including corporate strategy, new product planning, medical evidence strategy, commercial go-to-market, pricing and market access, and patient services) with Communications services (spanning advertising, medical communications, and payer communications). The company also maintains a Technology Suite. Recent acquisitions of Kx Advisors (healthcare strategy consultancy) and Hayden Consulting Group (market access and patient services consultancy) have expanded the firm's strategic advisory capabilities, integrating approximately 80-100 Hayden employees under Chief of Commercial Strategy and Innovation Hilary Gentile.

Differentiator

Problem solved

Functional benefit

Products and services

• Consulting Services

Quantifiable outcome

• 4% revenue growth in 2024, with nearly half of that growth coming from new clients

Segments2 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Two partnerships are on record, tiered core.

• Kx AdvisorscoreStrategic or Co-development PartnerKx Advisors was acquired by BGB Group in September 2023. The healthcare strategy consultancy brought expertise in healthcare strategy and consulting services, expanding BGB's capabilities in the healthcare sector.
• Hayden Consulting GroupcoreStrategic or Co-development PartnerHayden Consulting Group, co-founded by Jamie Sidore and David MacDougall, was acquired by BGB Group in January 2026. The premier market access and patient services consultancy specializes in payer, reimbursement, and affordability challenges for global pharmaceutical brands, integrating into BGB's Strategic Advisory practice.

Scale indicators4 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• ZS Associates: ZS Associates is a global consulting firm specializing in pharma strategy, market access, and commercial operations. It is a direct competitor in BGB's strategic consulting and market access service lines.
• Fingerpaint: Fingerpaint is a healthcare-focused marketing and communications agency offering strategy, creative, and omnichannel engagement. It competes directly in BGB's advertising and medical communications services.
• Trinity Life Sciences: Trinity Life Sciences provides strategic consulting, benchmarking, and insights to pharma and biotech. It competes directly with BGB's strategy consulting and intelligence & analytics practices.
• Fishawack Health: Fishawack Health is a healthcare communications and consulting group offering medical communications, consulting, and creative services to pharma. It competes directly in BGB's medical communications and strategy consulting lines.
• EVERSANA: EVERSANA is an independent pharma services platform spanning market access, patient services, and commercial strategy. It is highly comparable to BGB's integrated strategic advisory offering, particularly post-Hayden acquisition.
• Lumanity: Lumanity is a life sciences consulting and commercialization firm focused on strategy, evidence, and access. It competes in BGB's strategic advisory space, particularly in evidence strategy and market access.
• Syneos Health: Syneos Health is a large pharma services platform combining commercial strategy, medical communications, and clinical capabilities. It is directly comparable as an integrated commercialization partner serving the same pharma/life sciences buyer base.
• Publicis Health: Publicis Health is a healthcare-focused communications and advertising network within Publicis Groupe, competing directly in medical communications, payer communications, and HCP engagement services for pharma clients.

Broad incumbents

• IQVIA: IQVIA is a global leader in life sciences data, analytics, and consulting, with broad capabilities across commercial strategy, market access, and R&D. It is a broad incumbent overlapping multiple BGB service lines.
• Accenture Life Sciences: Accenture's Life Sciences practice offers strategy, consulting, and digital transformation services to pharma. It is a broader incumbent competing for enterprise pharma transformation and consulting engagements.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/bgb-group
• Facebookfacebook.com/profile.php

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BGB Group